Oncology and Hematology
1-16 of 157
- MinuteCE®
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
1.00 credit 10 episodes
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
A.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
1.00 program creditA.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
- MinuteCE®
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
1.00 program creditA.J. Gelderblom, MD, PhD
- MinuteCE®
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
1.00 program creditA.J. Gelderblom, MD, PhD
Chelsea Cole, MD
A.J. Gelderblom, MD, PhD
- MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
1.00 program creditA.J. Gelderblom, MD, PhD
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
Giuseppe Curigliano, MD, PhD
Cynthia Villarreal-Garza, MD, DSc
Komal Jhaveri, MD, FACP
Hiraji Iwata, MD, PhD
- MinuteCE®
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
1.00 program creditKomal Jhaveri, MD, FACP
- MinuteCE®
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
1.00 program creditGiuseppe Curigliano, MD, PhD
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Komal Jhaveri, MD, FACP
- Prev
- Next